Professionals 240 Users Online

Bone Marrow Transplantation Market

Global Market Study on Bone Marrow Transplantation: Rising incidences of Cancer to drive market expansion

Bone Marrow Transplantation Market Segmented by autologous bone marrow transplantation and allogeneic bone marrow transplantation Type with leukemia, lymphoma, myeloma, myelodysplasia, myeloproliferative neoplasms, aplastic anemia, solid tumors, sickle cell anemia, thalassemia Indication

Bone Marrow Transplantation Market Outlook (2022 - 2028)

The procedure of replacing damaged bone marrow stem cells with healthy tissue is known as bone marrow transplantation. Bone marrow is a soft vascular substance found inside long bones that are principally responsible for hematopoiesis (the generation of blood cells), lymphocyte synthesis, and fat storage. The procedure of bone marrow transplantation is prescribed for the treatment of advanced stages of leukemia, Hodgkin, and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, thalassemia, and the other diseases. Increasing awareness, combined with an increase in initiatives run by healthcare practitioners, is majorly responsible for the global growth of Bone Marrow Transplantation Market. The global Bone Marrow Transplantation market is estimated at $ 10,357.1 million in 2022 and is expected to grow at a CAGR of 3.7% from 2022 to 2028, reaching $ 12,856 million by 2028.

Attribute Key Insights

Bone Marrow Transplantation Market Size (2022)

US$ 10,357.1 Mn

Projected Market Value (2028)

US$ 12,856.0 Mn

Global Market Growth Rate (2022 - 2028)

3.7% CAGR

Share in parent market


Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Bone Marrow Transplantation Market Demand Analysis (2013-2021) v/s Market Outlook (2022 - 2028)

The rising prevalence of blood cancer, combined with the ease of access to bone marrow transplantation therapy, is driving the market for bone marrow transplantation. Furthermore, the commercialization of cell therapy and tissue engineering products is fueling the market growth.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Key Drivers to the Bone Marrow Transplantation Market

  • “Rising Adoption of Bone Marrow Transplantations”

The adoption of bone marrow transplantation procedures has increased significantly in the last few years because of the high Patient survival rates. Bone marrow transplantation is regarded as the most effective and guaranteed therapy choice for advanced leukemia and the other blood cancers.


  • “Increasing Prevalence of Cancers And Anemia”

The rising prevalence of cancer and anemia is the primary driver of the global bone marrow transplant market. To treat advanced stages of blood cancer, sickle cell anemia, and the other chronic diseases, a bone marrow transplantation procedure is recommended. Bone marrow transplantation procedures are regarded as the most efficient and reliable treatment options for certain chronic diseases.

  • “Technological Advancements”

Technological advancements and improved healthcare infrastructure are expected to drive market growth. Extensive research activities and an increase in the number of product launches will enhance the growth of the market throughout the predicted period. Apart from this, emerging indications of bone marrow transplant for cardiac and neurological problems, increasing investment in logistic services, and rising per capita healthcare spending are some of the other factors likely to drive the global bone marrow transplantation market.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Restraints to the Bone Marrow Transplantation Market

  • “High Cost of the Treatment”

The high cost of therapy, along with a lack of reimbursement policies, has slowed down the acceptance of bone marrow transplantation. Besides, lack of bone marrow donors is a major impediment to the growth of the global bone marrow transplantation market.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Impact of COVID-19 on Bone Marrow Transplantation Market

The Covid-19 pandemic resulted into a huge burden on the global healthcare facilities because of the rising covid-19 positive patients between March 2020 and September 2021. Healthcare facilities around the world were flooded with Covid-19 patients, which resulted into the cancellation or postponement of the other procedures. Hence, the Covid-19 outbreak had a negative impact on the Bone Marrow Transplantation Market.

Competitive Landscape

The Bone Marrow Transplantation market is highly competitive and consists of a number of major players. To increase their global market presence, market leaders are engaging in various product launches and development activities focusing on orthopedic surgical treatments.

Bone Marrow Transplantation Market Industry Report Scope

Attribute Details

Forecast Period

2022 - 2028

Historical Data Available for


Market Analysis

US$ Mn/Bn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Countries Covered

  • U.S.
  • Canada
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • Russia
  • India
  • China
  • Japan
  • UAE
  • Australia

Key Market Segments Covered

By End User

Key Companies Profiled

  • Merck Millipore Corporation
  • Sanofi-Aventis LLC.
  • STEMCELL Technologies.
  • American Type Culture Collection (ATCC) Inc
  • ReeLabs Pvt. Ltd.
  • HemaCare

Customization & Pricing

Available upon Request

Bone Marrow Transplantation Market Categorization

Bone Marrow Transplantation Market by End User

  • Hospitals
  • Multispecialty Clinics
  • Ambulatory Surgical Centers

Bone Marrow Transplantation Market by Transplant Type

  • Autologous Bone Marrow Transplant
  • Allogeneic Bone marrow Transplant

Bone Marrow Transplantation Market by Disease Indication

  • Leukemia
  • Lymphoma
  • Myeloma
  • Others

Bone Marrow Transplantation Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

- Companies Covered in This Report -

  • Lonza Group Ltd.
  • Merck Millipore Corporation
  • Sanofi-Aventis LLC.
  • STEMCELL Technologies.
  • American Type Culture Collection (ATCC) Inc
  • ReeLabs Pvt. Ltd.
  • HemaCare

- Frequently Asked Questions -

In 2022, the Bone Marrow Transplantation Market stands at USD 10,357.1 million, and it is expected to reach USD 12,856 million by 2028 at a CAGR of 3.7%.

Bone Marrow Transplantation Market exhibited a CAGR of 3.1% between 2013 and 2021.

High cost of the treatment and a lack of bone marrow donors are the key restraints in the Bone Marrow Transplantation Market.

Rising Adoption of Bone Marrow Transplantations and Increasing Prevalence of Cancers and Anemia are the key factors driving the growth of the market.

Merck Millipore Corporation, Sanofi-Aventis LLC., STEMCELL Technologies., American Type Culture Collection (ATCC) Inc, ReeLabs Pvt. Ltd., and HemaCare are among the top players in the market.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate